The escalating prevalence of obesity and type 2 diabetes has spurred innovation in therapeutic solutions, and the spotlight ...

Sponsored Content In adults with obesity, retatrutide treatment for 24-48 weeks resulted in substantial reductions in body weight, with dose-dependent efficacy. Research in Metabolic Disorders ...